These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 21897412)
1. Is the lymphoma risk reduced in viral hepatitis? A cirrhotic patient with triple malignancies. Doganay L; Kiziltas S; Colak Y; Gulluoglu M; Tuncer I Am J Gastroenterol; 2011 Sep; 106(9):1719-20; author reply 1720. PubMed ID: 21897412 [No Abstract] [Full Text] [Related]
2. Losses to follow-up limit conclusions regarding the efficacy of branched-chain amino acids in patients with hepatic encephalopathy. Mumtaz S; Ford AC Am J Gastroenterol; 2011 Sep; 106(9):1718; author reply 1718-9. PubMed ID: 21897411 [No Abstract] [Full Text] [Related]
3. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study. Les I; Doval E; García-Martínez R; Planas M; Cárdenas G; Gómez P; Flavià M; Jacas C; Mínguez B; Vergara M; Soriano G; Vila C; Esteban R; Córdoba J Am J Gastroenterol; 2011 Jun; 106(6):1081-8. PubMed ID: 21326220 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of Levocarnitine and/or Branched-Chain Amino Acids during Invasive Treatment for Hepatocellular Carcinoma. Iwasa M; Sugimoto R; Ishihara T; Sekoguchi-Fujikawa N; Yoshikawa K; Mifuji-Moroka R; Tanaka H; Kobayashi Y; Hasegawa H; Takei Y J Nutr Sci Vitaminol (Tokyo); 2015; 61(6):433-40. PubMed ID: 26875483 [TBL] [Abstract][Full Text] [Related]
6. Care of the cirrhotic patient. Grewal P; Martin P Clin Liver Dis; 2009 May; 13(2):331-40. PubMed ID: 19442922 [TBL] [Abstract][Full Text] [Related]
7. [Liver cirrhosis--current aspects of diagnosis and therapy.2: therapy of complications]. Held C Z Arztl Fortbild (Jena); 1990; 84(16):819-24. PubMed ID: 2171234 [No Abstract] [Full Text] [Related]
8. New support for branched-chain amino acid supplementation in advanced hepatic failure. Mascarenhas R; Mobarhan S Nutr Rev; 2004 Jan; 62(1):33-8. PubMed ID: 14995055 [TBL] [Abstract][Full Text] [Related]
11. [The dietary protein contribution and hepatic encephalopathy in cirrhosis]. Zavaglia C; Brivio M; Losacco E; Onida L Recenti Prog Med; 1992 Apr; 83(4):218-23. PubMed ID: 1626117 [TBL] [Abstract][Full Text] [Related]
12. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma. Takeshita S; Ichikawa T; Nakao K; Miyaaki H; Shibata H; Matsuzaki T; Muraoka T; Honda T; Otani M; Akiyama M; Miuma S; Ozawa E; Fujimito M; Eguchi K Nutr Res; 2009 Feb; 29(2):89-93. PubMed ID: 19285598 [TBL] [Abstract][Full Text] [Related]
13. Branched-chain amino acid-enriched elemental diet in patients with cirrhosis of the liver. A double blind crossover trial. Sieg A; Walker S; Czygan P; Gärtner U; Lanzinger-Rossnagel G; Stiehl A; Kommerell B Z Gastroenterol; 1983 Nov; 21(11):644-50. PubMed ID: 6362243 [TBL] [Abstract][Full Text] [Related]
14. Impairment of innate immune responses in cirrhotic patients and treatment by branched-chain amino acids. Nakamura I World J Gastroenterol; 2014 Jun; 20(23):7298-305. PubMed ID: 24966600 [TBL] [Abstract][Full Text] [Related]